Skip to content

Tiredness and Nausea and Vomiting Management in Oncology Patients

The Effect of Breath Exercise and Reiki Application on Tiredness and Nausea and Vomiting Management in Oncology Patients; Randomised Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07069023
Enrollment
60
Registered
2025-07-16
Start date
2023-12-01
Completion date
2024-05-30
Last updated
2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Fatigue, Nausea

Keywords

Breath exercise, reiki application, tiredness, nausea, vomiting

Brief summary

This randomised controlled trial will investigate the effects of breathing exercises and Reiki on fatigue and nausea-vomiting symptoms in oncology patients. Data will be collected through face-to-face interviews using structured forms before the start of chemotherapy. To account for possible losses, 20 patients will be included in each intervention group.

Detailed description

Objective: This study aims to investigate the effects of breathing exercises and reiki on symptoms of fatigue, nausea, and vomiting. Experimental procedure: This randomised controlled trial will be conducted to investigate the effects of breathing exercises and reiki on symptoms of fatigue, nausea, and vomiting in oncology patients. Data will be collected using data collection forms during approximately 30-minute face-to-face interviews immediately before patients begin chemotherapy treatment. Considering that there may be case losses during the study, it was decided to include 20 patients in each group.

Interventions

Oncology patients with nausea, vomiting and fatigue were given breathing exercises throughout the treatment.

Oncology patients with nausea, vomiting and fatigue received reiki throughout the treatment.

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This study employed a three-group experimental design involving a breathing exercise group, a Reiki group, and a control group. Participants in the intervention groups received sessions twice a week for six weeks, while the control group received no intervention. Data were collected at three points: pre-test (week 1), mid-test (week 3), and post-test (week 6), using validated instruments. These assessments aimed to measure changes over time and compare group differences. Ethical approval was obtained, and informed consent was secured from all participants.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients who volunteered to participate in the study, were diagnosed with cancer, had symptoms of nausea-vomiting and fatigue, were literate, could communicate, did not have a diagnosis of mental or psychiatric illness, were not hearing or visually impaired, were 18 years of age or older, and were not receiving antiemetic treatment. \-

Exclusion criteria

Patients with any other disease related to the gastrointestinal system, any other disease or condition that would prevent them from performing the exercises to be performed for the study. \-

Design outcomes

Primary

MeasureTime frameDescription
Individual Introductory Information Form6 WEEKSIt was consists of questions such as socio-demographic characteristics such as age, marital status, chronic diseases, disease history, and type, stage, metastasis status, metastasis site, treatment status, nausea and vomiting
Hirai Cancer Fatigue Scale6 WEEKSThe scale measures fatigue in cancer patients and is 5-point Likert type. The minimum value of the scale is 15 and the maximum value is 75. High scores on the scale indicate increased fatigue and low scores indicate decreased fatigue.The Cronbach Alpha value of the original scale was found to be 0.943.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026